The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver-Reference-Cited by-同舟云学术

The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver

Published:2017-07-05 Issue:7 Volume:18 Page:1447
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Takahashi Yutaka

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/7/1447/pdf

Reference91 articles.

1. Nonalcoholic Fatty Liver Disease

2. Prevalence, gender, ethnic variations, and prognosis of NASH

3. Aisf position paper on nonalcoholic fatty liver disease (nafld): Updates and future directions;Dig. Liver Dis.,2017

4. Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice

5. Diagnostic evaluation of nonalcoholic fatty liver disease;Adams;J. Clin. Gastroenterol.,2006

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-arrestin2 promotes angiogenesis of liver sinusoidal endothelial cells through the VEGF/VEGFR2 pathway to aggravate cirrhosis;Toxicology Letters;2024-11

2. Sarcopenia in cirrhosis: From pathophysiology to interventional therapy;Experimental Gerontology;2024-10

3. Emerging role of liver-bone axis in osteoporosis;Journal of Orthopaedic Translation;2024-09

4. Correlation of tri-ponderal mass index with insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children and adolescents;Annals of Pediatric Endocrinology & Metabolism;2024-08-31

5. Physical frailty, genetic predisposition, and the risks of severe non‐alcoholic fatty liver disease and cirrhosis: a cohort study;Journal of Cachexia, Sarcopenia and Muscle;2024-06-18